How big is the myasthenia gravis market?

HighlightsThe global Myasthenia Gravis market was valued at US 1348.8 million in 2022 and is anticipated to reach US 2442 million by 2029 witnessing a CAGR of 10.4 during the forecast period 20232029.

Who are the key players in the myasthenia gravis market?

Some of the key players are Companies, Grifols S A, Grifols, Others.

Global Myasthenia Gravis Market Research Report 2023

BUY CHAPTERS

Global Myasthenia Gravis Market Insights, Forecast to 2029

Code: QYRE-Auto-3D13735

Report

June 2023

Pages:113

QYResearch

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Takeda

F.Hoffmann-La Roche

CSL Behring

Alexion Pharmaceutical

Avadel Pharmaceuticals

Baxter International

Novartis

Bausch Health

Takeda Pharmaceutical Company

Myasthenia Gravis Market Size

The global Myasthenia Gravis market is projected to grow from US$ 1348.8 million in 2023 to US$ 2442 million by 2029, at a Compound Annual Growth Rate (CAGR) of 10.4% during the forecast period.

Myasthenia Gravis Market

Market Analysis and Insights: Global Myasthenia Gravis Market

The US & Canada market for Myasthenia Gravis is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The China market for Myasthenia Gravis is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The Europe market for Myasthenia Gravis is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The global key companies of Myasthenia Gravis include Takeda, F. Hoffmann-La Roche, CSL Behring, Grifols, Alexion Pharmaceutical, Avadel Pharmaceuticals, Baxter International, Novartis and Bausch Health, etc. in 2022, the global top five players had a share approximately % in terms of revenue.

Report Includes

This report presents an overview of global market for Myasthenia Gravis market size. Analyses of the global market trends, with historic market revenue data for 2018 - 2022, estimates for 2023, and projections of CAGR through 2029.

This report researches the key producers of Myasthenia Gravis, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Myasthenia Gravis, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Myasthenia Gravis revenue, market share and industry ranking of main companies, data from 2018 to 2023. Identification of the major stakeholders in the global Myasthenia Gravis market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by type and by application, revenue, and growth rate, from 2018 to 2029. Evaluation and forecast the market size for Myasthenia Gravis revenue, projected growth trends, production technology, application and end-user industry.

Descriptive company profiles of the major global players, including Takeda, F. Hoffmann-La Roche, CSL Behring, Grifols, Alexion Pharmaceutical, Avadel Pharmaceuticals, Baxter International, Novartis and Bausch Health, etc.

Scope of Myasthenia Gravis Market Report

Report Metric	Details
Report Name	Myasthenia Gravis Market
Accounted market size in 2023	US$ 1348.8 million
Forecasted market size in 2029	US$ 2442 million
Base Year	2023
Forecasted years	2023 - 2029
Segment by Type	Drug Treatment Rapid Immunotherapies
Segment by Application	Hospitals Clinics Other
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Takeda, F. Hoffmann-La Roche, CSL Behring, Grifols, Alexion Pharmaceutical, Avadel Pharmaceuticals, Baxter International, Novartis, Bausch Health, Takeda Pharmaceutical Company
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Myasthenia Gravis in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Myasthenia Gravis companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by type, by application and by country, revenue for each segment.
Chapter 7: Europe by type, by application and by country, revenue for each segment.
Chapter 8: China by type and by application revenue for each segment.
Chapter 9: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by type, by application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Myasthenia Gravis revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Myasthenia Gravis Market Size Growth Rate by Type, 2018 VS 2022 VS 2029

1.2.2 Drug Treatment

1.2.3 Rapid Immunotherapies

1.3 Market by Application

1.3.1 Global Myasthenia Gravis Market Size Growth Rate by Application, 2018 VS 2022 VS 2029

1.3.2 Hospitals

1.3.3 Clinics

1.3.4 Other

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Myasthenia Gravis Market Perspective (2018-2029)

2.2 Global Myasthenia Gravis Growth Trends by Region

2.2.1 Myasthenia Gravis Market Size by Region: 2018 VS 2022 VS 2029

2.2.2 Myasthenia Gravis Historic Market Size by Region (2018-2023)

2.2.3 Myasthenia Gravis Forecasted Market Size by Region (2024-2029)

2.3 Myasthenia Gravis Market Dynamics

2.3.1 Myasthenia Gravis Industry Trends

2.3.2 Myasthenia Gravis Market Drivers

2.3.3 Myasthenia Gravis Market Challenges

2.3.4 Myasthenia Gravis Market Restraints

3 Competition Landscape by Key Players

3.1 Global Revenue Myasthenia Gravis by Players

3.1.1 Global Myasthenia Gravis Revenue by Players (2018-2023)

3.1.2 Global Myasthenia Gravis Revenue Market Share by Players (2018-2023)

3.2 Global Myasthenia Gravis Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players of Myasthenia Gravis, Ranking by Revenue, 2021 VS 2022 VS 2023

3.4 Global Myasthenia Gravis Market Concentration Ratio

3.4.1 Global Myasthenia Gravis Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Myasthenia Gravis Revenue in 2022

3.5 Global Key Players of Myasthenia Gravis Head office and Area Served

3.6 Global Key Players of Myasthenia Gravis, Product and Application

3.7 Global Key Players of Myasthenia Gravis, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Myasthenia Gravis Breakdown Data by Type

4.1 Global Myasthenia Gravis Historic Market Size by Type (2018-2023)

4.2 Global Myasthenia Gravis Forecasted Market Size by Type (2024-2029)

5 Myasthenia Gravis Breakdown Data by Application

5.1 Global Myasthenia Gravis Historic Market Size by Application (2018-2023)

5.2 Global Myasthenia Gravis Forecasted Market Size by Application (2024-2029)

6 North America

6.1 North America Myasthenia Gravis Market Size (2018-2029)

6.2 North America Myasthenia Gravis Market Size by Type

6.2.1 North America Myasthenia Gravis Market Size by Type (2018-2023)

6.2.2 North America Myasthenia Gravis Market Size by Type (2024-2029)

6.2.3 North America Myasthenia Gravis Market Share by Type (2018-2029)

6.3 North America Myasthenia Gravis Market Size by Application

6.3.1 North America Myasthenia Gravis Market Size by Application (2018-2023)

6.3.2 North America Myasthenia Gravis Market Size by Application (2024-2029)

6.3.3 North America Myasthenia Gravis Market Share by Application (2018-2029)

6.4 North America Myasthenia Gravis Market Size by Country

6.4.1 North America Myasthenia Gravis Market Size by Country: 2018 VS 2022 VS 2029

6.4.2 North America Myasthenia Gravis Market Size by Country (2018-2023)

6.4.3 North America Myasthenia Gravis Market Size by Country (2024-2029)

6.4.4 U.S.

6.4.5 Canada

7 Europe

7.1 Europe Myasthenia Gravis Market Size (2018-2029)

7.2 Europe Myasthenia Gravis Market Size by Type

7.2.1 Europe Myasthenia Gravis Market Size by Type (2018-2023)

7.2.2 Europe Myasthenia Gravis Market Size by Type (2024-2029)

7.2.3 Europe Myasthenia Gravis Market Share by Type (2018-2029)

7.3 Europe Myasthenia Gravis Market Size by Application

7.3.1 Europe Myasthenia Gravis Market Size by Application (2018-2023)

7.3.2 Europe Myasthenia Gravis Market Size by Application (2024-2029)

7.3.3 Europe Myasthenia Gravis Market Share by Application (2018-2029)

7.4 Europe Myasthenia Gravis Market Size by Country

7.4.1 Europe Myasthenia Gravis Market Size by Country: 2018 VS 2022 VS 2029

7.4.2 Europe Myasthenia Gravis Market Size by Country (2018-2023)

7.4.3 Europe Myasthenia Gravis Market Size by Country (2024-2029)

7.4.3 Germany

7.4.4 France

7.4.5 U.K.

7.4.6 Italy

7.4.7 Russia

7.4.8 Nordic Countries

8 China

8.1 China Myasthenia Gravis Market Size (2018-2029)

8.2 China Myasthenia Gravis Market Size by Type

8.2.1 China Myasthenia Gravis Market Size by Type (2018-2023)

8.2.2 China Myasthenia Gravis Market Size by Type (2024-2029)

8.2.3 China Myasthenia Gravis Market Share by Type (2018-2029)

8.3 China Myasthenia Gravis Market Size by Application

8.3.1 China Myasthenia Gravis Market Size by Application (2018-2023)

8.3.2 China Myasthenia Gravis Market Size by Application (2024-2029)

8.3.3 China Myasthenia Gravis Market Share by Application (2018-2029)

9 Asia (excluding China)

9.1 Asia Myasthenia Gravis Market Size (2018-2029)

9.2 Asia Myasthenia Gravis Market Size by Type

9.2.1 Asia Myasthenia Gravis Market Size by Type (2018-2023)

9.2.2 Asia Myasthenia Gravis Market Size by Type (2024-2029)

9.2.3 Asia Myasthenia Gravis Market Share by Type (2018-2029)

9.3 Asia Myasthenia Gravis Market Size by Application

9.3.1 Asia Myasthenia Gravis Market Size by Application (2018-2023)

9.3.2 Asia Myasthenia Gravis Market Size by Application (2024-2029)

9.3.3 Asia Myasthenia Gravis Market Share by Application (2018-2029)

9.4 Asia Myasthenia Gravis Market Size by Region

9.4.1 Asia Myasthenia Gravis Market Size by Region: 2018 VS 2022 VS 2029

9.4.2 Asia Myasthenia Gravis Market Size by Region (2018-2023)

9.4.3 Asia Myasthenia Gravis Market Size by Region (2024-2029)

9.4.4 Japan

9.4.5 South Korea

9.4.6 China Taiwan

9.4.7 Southeast Asia

9.4.8 India

9.4.9 Australia

10 Middle East, Africa, and Latin America

10.1 Middle East, Africa, and Latin America Myasthenia Gravis Market Size (2018-2029)

10.2 Middle East, Africa, and Latin America Myasthenia Gravis Market Size by Type

10.2.1 Middle East, Africa, and Latin America Myasthenia Gravis Market Size by Type (2018-2023)

10.2.2 Middle East, Africa, and Latin America Myasthenia Gravis Market Size by Type (2024-2029)

10.2.3 Middle East, Africa, and Latin America Myasthenia Gravis Market Share by Type (2018-2029)

10.3 Middle East, Africa, and Latin America Myasthenia Gravis Market Size by Application

10.3.1 Middle East, Africa, and Latin America Myasthenia Gravis Market Size by Application (2018-2023)

10.3.2 Middle East, Africa, and Latin America Myasthenia Gravis Market Size by Application (2024-2029)

10.3.3 Middle East, Africa, and Latin America Myasthenia Gravis Market Share by Application (2018-2029)

10.4 Middle East, Africa, and Latin America Myasthenia Gravis Market Size by Country

10.4.1 Middle East, Africa, and Latin America Myasthenia Gravis Market Size by Country: 2018 VS 2022 VS 2029

10.4.2 Middle East, Africa, and Latin America Myasthenia Gravis Market Size by Country (2018-2023)

10.4.3 Middle East, Africa, and Latin America Myasthenia Gravis Market Size by Country (2024-2029)

10.4.4 Brazil

10.4.5 Mexico

10.4.6 Turkey

10.4.7 Saudi Arabia

10.4.8 Israel

10.4.9 GCC Countries

11 Key Players Profiles

11.1 Takeda

11.1.1 Takeda Company Details

11.1.2 Takeda Business Overview

11.1.3 Takeda Myasthenia Gravis Introduction

11.1.4 Takeda Revenue in Myasthenia Gravis Business (2018-2023)

11.1.5 Takeda Recent Developments

11.2 F. Hoffmann-La Roche

11.2.1 F. Hoffmann-La Roche Company Details

11.2.2 F. Hoffmann-La Roche Business Overview

11.2.3 F. Hoffmann-La Roche Myasthenia Gravis Introduction

11.2.4 F. Hoffmann-La Roche Revenue in Myasthenia Gravis Business (2018-2023)

11.2.5 F. Hoffmann-La Roche Recent Developments

11.3 CSL Behring

11.3.1 CSL Behring Company Details

11.3.2 CSL Behring Business Overview

11.3.3 CSL Behring Myasthenia Gravis Introduction

11.3.4 CSL Behring Revenue in Myasthenia Gravis Business (2018-2023)

11.3.5 CSL Behring Recent Developments

11.4 Grifols

11.4.1 Grifols Company Details

11.4.2 Grifols Business Overview

11.4.3 Grifols Myasthenia Gravis Introduction

11.4.4 Grifols Revenue in Myasthenia Gravis Business (2018-2023)

11.4.5 Grifols Recent Developments

11.5 Alexion Pharmaceutical

11.5.1 Alexion Pharmaceutical Company Details

11.5.2 Alexion Pharmaceutical Business Overview

11.5.3 Alexion Pharmaceutical Myasthenia Gravis Introduction

11.5.4 Alexion Pharmaceutical Revenue in Myasthenia Gravis Business (2018-2023)

11.5.5 Alexion Pharmaceutical Recent Developments

11.6 Avadel Pharmaceuticals

11.6.1 Avadel Pharmaceuticals Company Details

11.6.2 Avadel Pharmaceuticals Business Overview

11.6.3 Avadel Pharmaceuticals Myasthenia Gravis Introduction

11.6.4 Avadel Pharmaceuticals Revenue in Myasthenia Gravis Business (2018-2023)

11.6.5 Avadel Pharmaceuticals Recent Developments

11.7 Baxter International

11.7.1 Baxter International Company Details

11.7.2 Baxter International Business Overview

11.7.3 Baxter International Myasthenia Gravis Introduction

11.7.4 Baxter International Revenue in Myasthenia Gravis Business (2018-2023)

11.7.5 Baxter International Recent Developments

11.8 Novartis

11.8.1 Novartis Company Details

11.8.2 Novartis Business Overview

11.8.3 Novartis Myasthenia Gravis Introduction

11.8.4 Novartis Revenue in Myasthenia Gravis Business (2018-2023)

11.8.5 Novartis Recent Developments

11.9 Bausch Health

11.9.1 Bausch Health Company Details

11.9.2 Bausch Health Business Overview

11.9.3 Bausch Health Myasthenia Gravis Introduction

11.9.4 Bausch Health Revenue in Myasthenia Gravis Business (2018-2023)

11.9.5 Bausch Health Recent Developments

11.10 Takeda Pharmaceutical Company

11.10.1 Takeda Pharmaceutical Company Company Details

11.10.2 Takeda Pharmaceutical Company Business Overview

11.10.3 Takeda Pharmaceutical Company Myasthenia Gravis Introduction

11.10.4 Takeda Pharmaceutical Company Revenue in Myasthenia Gravis Business (2018-2023)

11.10.5 Takeda Pharmaceutical Company Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Takeda

F.Hoffmann-La Roche

CSL Behring

Alexion Pharmaceutical

Avadel Pharmaceuticals

Baxter International

Novartis

Bausch Health

Takeda Pharmaceutical Company

List of Tables

Table 1. Global Myasthenia Gravis Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029

Table 2. Key Players of Drug Treatment

Table 3. Key Players of Rapid Immunotherapies

Table 4. Global Myasthenia Gravis Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029

Table 5. Global Myasthenia Gravis Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029

Table 6. Global Myasthenia Gravis Market Size by Region (2018-2023) & (US$ Million)

Table 7. Global Myasthenia Gravis Market Share by Region (2018-2023)

Table 8. Global Myasthenia Gravis Forecasted Market Size by Region (2024-2029) & (US$ Million)

Table 9. Global Myasthenia Gravis Market Share by Region (2024-2029)

Table 10. Myasthenia Gravis Market Trends

Table 11. Myasthenia Gravis Market Drivers

Table 12. Myasthenia Gravis Market Challenges

Table 13. Myasthenia Gravis Market Restraints

Table 14. Global Myasthenia Gravis Revenue by Players (2018-2023) & (US$ Million)

Table 15. Global Myasthenia Gravis Revenue Share by Players (2018-2023)

Table 16. Global Top Myasthenia Gravis by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Myasthenia Gravis as of 2022)

Table 17. Global Myasthenia Gravis Industry Ranking 2021 VS 2022 VS 2023

Table 18. Global 5 Largest Players Market Share by Myasthenia Gravis Revenue (CR5 and HHI) & (2018-2023)

Table 19. Global Key Players of Myasthenia Gravis, Headquarters and Area Served

Table 20. Global Key Players of Myasthenia Gravis, Product and Application

Table 21. Global Key Players of Myasthenia Gravis, Product and Application

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Myasthenia Gravis Market Size by Type (2018-2023) & (US$ Million)

Table 24. Global Myasthenia Gravis Revenue Market Share by Type (2018-2023)

Table 25. Global Myasthenia Gravis Forecasted Market Size by Type (2024-2029) & (US$ Million)

Table 26. Global Myasthenia Gravis Revenue Market Share by Type (2024-2029)

Table 27. Global Myasthenia Gravis Market Size by Application (2018-2023) & (US$ Million)

Table 28. Global Myasthenia Gravis Revenue Share by Application (2018-2023)

Table 29. Global Myasthenia Gravis Forecasted Market Size by Application (2024-2029) & (US$ Million)

Table 30. Global Myasthenia Gravis Revenue Share by Application (2024-2029)

Table 31. North America Myasthenia Gravis Market Size by Type (2018-2023) & (US$ Million)

Table 32. North America Myasthenia Gravis Market Size by Type (2024-2029) & (US$ Million)

Table 33. North America Myasthenia Gravis Market Size by Application (2018-2023) & (US$ Million)

Table 34. North America Myasthenia Gravis Market Size by Application (2024-2029) & (US$ Million)

Table 35. North America Myasthenia Gravis Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029

Table 36. North America Myasthenia Gravis Market Size by Country (2018-2023) & (US$ Million)

Table 37. North America Myasthenia Gravis Market Size by Country (2024-2029) & (US$ Million)

Table 38. Europe Myasthenia Gravis Market Size by Type (2018-2023) & (US$ Million)

Table 39. Europe Myasthenia Gravis Market Size by Type (2024-2029) & (US$ Million)

Table 40. Europe Myasthenia Gravis Market Size by Application (2018-2023) & (US$ Million)

Table 41. Europe Myasthenia Gravis Market Size by Application (2024-2029) & (US$ Million)

Table 42. Europe Myasthenia Gravis Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029

Table 43. Europe Myasthenia Gravis Market Size by Country (2018-2023) & (US$ Million)

Table 44. Europe Myasthenia Gravis Market Size by Country (2024-2029) & (US$ Million)

Table 45. China Myasthenia Gravis Market Size by Type (2018-2023) & (US$ Million)

Table 46. China Myasthenia Gravis Market Size by Type (2024-2029) & (US$ Million)

Table 47. China Myasthenia Gravis Market Size by Application (2018-2023) & (US$ Million)

Table 48. China Myasthenia Gravis Market Size by Application (2024-2029) & (US$ Million)

Table 49. Asia Myasthenia Gravis Market Size by Type (2018-2023) & (US$ Million)

Table 50. Asia Myasthenia Gravis Market Size by Type (2024-2029) & (US$ Million)

Table 51. Asia Myasthenia Gravis Market Size by Application (2018-2023) & (US$ Million)

Table 52. Asia Myasthenia Gravis Market Size by Application (2024-2029) & (US$ Million)

Table 53. Asia Myasthenia Gravis Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029

Table 54. Asia Myasthenia Gravis Market Size by Region (2018-2023) & (US$ Million)

Table 55. Asia Myasthenia Gravis Market Size by Region (2024-2029) & (US$ Million)

Table 56. Middle East, Africa, and Latin America Myasthenia Gravis Market Size by Type (2018-2023) & (US$ Million)

Table 57. Middle East, Africa, and Latin America Myasthenia Gravis Market Size by Type (2024-2029) & (US$ Million)

Table 58. Middle East, Africa, and Latin America Myasthenia Gravis Market Size by Application (2018-2023) & (US$ Million)

Table 59. Middle East, Africa, and Latin America Myasthenia Gravis Market Size by Application (2024-2029) & (US$ Million)

Table 60. Middle East, Africa, and Latin America Myasthenia Gravis Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029

Table 61. Middle East, Africa, and Latin America Myasthenia Gravis Market Size by Country (2018-2023) & (US$ Million)

Table 62. Middle East, Africa, and Latin America Myasthenia Gravis Market Size by Country (2024-2029) & (US$ Million)

Table 63. Takeda Company Details

Table 64. Takeda Business Overview

Table 65. Takeda Myasthenia Gravis Product

Table 66. Takeda Revenue in Myasthenia Gravis Business (2018-2023) & (US$ Million)

Table 67. Takeda Recent Developments

Table 68. F. Hoffmann-La Roche Company Details

Table 69. F. Hoffmann-La Roche Business Overview

Table 70. F. Hoffmann-La Roche Myasthenia Gravis Product

Table 71. F. Hoffmann-La Roche Revenue in Myasthenia Gravis Business (2018-2023) & (US$ Million)

Table 72. F. Hoffmann-La Roche Recent Developments

Table 73. CSL Behring Company Details

Table 74. CSL Behring Business Overview

Table 75. CSL Behring Myasthenia Gravis Product

Table 76. CSL Behring Revenue in Myasthenia Gravis Business (2018-2023) & (US$ Million)

Table 77. CSL Behring Recent Developments

Table 78. Grifols Company Details

Table 79. Grifols Business Overview

Table 80. Grifols Myasthenia Gravis Product

Table 81. Grifols Revenue in Myasthenia Gravis Business (2018-2023) & (US$ Million)

Table 82. Grifols Recent Developments

Table 83. Alexion Pharmaceutical Company Details

Table 84. Alexion Pharmaceutical Business Overview

Table 85. Alexion Pharmaceutical Myasthenia Gravis Product

Table 86. Alexion Pharmaceutical Revenue in Myasthenia Gravis Business (2018-2023) & (US$ Million)

Table 87. Alexion Pharmaceutical Recent Developments

Table 88. Avadel Pharmaceuticals Company Details

Table 89. Avadel Pharmaceuticals Business Overview

Table 90. Avadel Pharmaceuticals Myasthenia Gravis Product

Table 91. Avadel Pharmaceuticals Revenue in Myasthenia Gravis Business (2018-2023) & (US$ Million)

Table 92. Avadel Pharmaceuticals Recent Developments

Table 93. Baxter International Company Details

Table 94. Baxter International Business Overview

Table 95. Baxter International Myasthenia Gravis Product

Table 96. Baxter International Revenue in Myasthenia Gravis Business (2018-2023) & (US$ Million)

Table 97. Baxter International Recent Developments

Table 98. Novartis Company Details

Table 99. Novartis Business Overview

Table 100. Novartis Myasthenia Gravis Product

Table 101. Novartis Revenue in Myasthenia Gravis Business (2018-2023) & (US$ Million)

Table 102. Novartis Recent Developments

Table 103. Bausch Health Company Details

Table 104. Bausch Health Business Overview

Table 105. Bausch Health Myasthenia Gravis Product

Table 106. Bausch Health Revenue in Myasthenia Gravis Business (2018-2023) & (US$ Million)

Table 107. Bausch Health Recent Developments

Table 108. Takeda Pharmaceutical Company Company Details

Table 109. Takeda Pharmaceutical Company Business Overview

Table 110. Takeda Pharmaceutical Company Myasthenia Gravis Product

Table 111. Takeda Pharmaceutical Company Revenue in Myasthenia Gravis Business (2018-2023) & (US$ Million)

Table 112. Takeda Pharmaceutical Company Recent Developments

Table 113. Research Programs/Design for This Report

Table 114. Key Data Information from Secondary Sources

Table 115. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Myasthenia Gravis Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)

Figure 2. Global Myasthenia Gravis Market Share by Type: 2022 VS 2029

Figure 3. Drug Treatment Features

Figure 4. Rapid Immunotherapies Features

Figure 5. Global Myasthenia Gravis Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)

Figure 6. Global Myasthenia Gravis Market Share by Application: 2022 VS 2029

Figure 7. Hospitals Case Studies

Figure 8. Clinics Case Studies

Figure 9. Other Case Studies

Figure 10. Myasthenia Gravis Report Years Considered

Figure 11. Global Myasthenia Gravis Market Size (US$ Million), Year-over-Year: 2018-2029

Figure 12. Global Myasthenia Gravis Market Size, (US$ Million), 2018 VS 2022 VS 2029

Figure 13. Global Myasthenia Gravis Market Share by Region: 2022 VS 2029

Figure 14. Global Myasthenia Gravis Market Share by Players in 2022

Figure 15. Global Top Myasthenia Gravis Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Myasthenia Gravis as of 2022)

Figure 16. The Top 10 and 5 Players Market Share by Myasthenia Gravis Revenue in 2022

Figure 17. North America Myasthenia Gravis Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 18. North America Myasthenia Gravis Market Share by Type (2018-2029)

Figure 19. North America Myasthenia Gravis Market Share by Application (2018-2029)

Figure 20. North America Myasthenia Gravis Market Share by Country (2018-2029)

Figure 21. United States Myasthenia Gravis Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 22. Canada Myasthenia Gravis Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 23. Europe Myasthenia Gravis Market Size YoY (2018-2029) & (US$ Million)

Figure 24. Europe Myasthenia Gravis Market Share by Type (2018-2029)

Figure 25. Europe Myasthenia Gravis Market Share by Application (2018-2029)

Figure 26. Europe Myasthenia Gravis Market Share by Country (2018-2029)

Figure 27. Germany Myasthenia Gravis Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 28. France Myasthenia Gravis Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 29. U.K. Myasthenia Gravis Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 30. Italy Myasthenia Gravis Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 31. Russia Myasthenia Gravis Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 32. Nordic Countries Myasthenia Gravis Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 33. China Myasthenia Gravis Market Size YoY (2018-2029) & (US$ Million)

Figure 34. China Myasthenia Gravis Market Share by Type (2018-2029)

Figure 35. China Myasthenia Gravis Market Share by Application (2018-2029)

Figure 36. Asia Myasthenia Gravis Market Size YoY (2018-2029) & (US$ Million)

Figure 37. Asia Myasthenia Gravis Market Share by Type (2018-2029)

Figure 38. Asia Myasthenia Gravis Market Share by Application (2018-2029)

Figure 39. Asia Myasthenia Gravis Market Share by Region (2018-2029)

Figure 40. Japan Myasthenia Gravis Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 41. South Korea Myasthenia Gravis Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 42. China Taiwan Myasthenia Gravis Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 43. Southeast Asia Myasthenia Gravis Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 44. India Myasthenia Gravis Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 45. Australia Myasthenia Gravis Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 46. Middle East, Africa, and Latin America Myasthenia Gravis Market Size YoY (2018-2029) & (US$ Million)

Figure 47. Middle East, Africa, and Latin America Myasthenia Gravis Market Share by Type (2018-2029)

Figure 48. Middle East, Africa, and Latin America Myasthenia Gravis Market Share by Application (2018-2029)

Figure 49. Middle East, Africa, and Latin America Myasthenia Gravis Market Share by Country (2018-2029)

Figure 50. Brazil Myasthenia Gravis Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 51. Mexico Myasthenia Gravis Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 52. Turkey Myasthenia Gravis Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 53. Saudi Arabia Myasthenia Gravis Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 54. Israel Myasthenia Gravis Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 55. GCC Countries Myasthenia Gravis Market Size YoY Growth (2018-2029) & (US$ Million)

Figure 56. Takeda Revenue Growth Rate in Myasthenia Gravis Business (2018-2023)

Figure 57. F. Hoffmann-La Roche Revenue Growth Rate in Myasthenia Gravis Business (2018-2023)

Figure 58. CSL Behring Revenue Growth Rate in Myasthenia Gravis Business (2018-2023)

Figure 59. Grifols Revenue Growth Rate in Myasthenia Gravis Business (2018-2023)

Figure 60. Alexion Pharmaceutical Revenue Growth Rate in Myasthenia Gravis Business (2018-2023)

Figure 61. Avadel Pharmaceuticals Revenue Growth Rate in Myasthenia Gravis Business (2018-2023)

Figure 62. Baxter International Revenue Growth Rate in Myasthenia Gravis Business (2018-2023)

Figure 63. Novartis Revenue Growth Rate in Myasthenia Gravis Business (2018-2023)

Figure 64. Bausch Health Revenue Growth Rate in Myasthenia Gravis Business (2018-2023)

Figure 65. Takeda Pharmaceutical Company Revenue Growth Rate in Myasthenia Gravis Business (2018-2023)

Figure 66. Bottom-up and Top-down Approaches for This Report

Figure 67. Data Triangulation

Figure 68. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (10% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

Global Myasthenia Gravis Market Insights, Forecast to 2029

Published Date: June 2023

Report Code: QYRE-Auto-3D13735

Global Myasthenia Gravis Market Insights, Forecast to 2029

FEATURED COMPANIES

Myasthenia Gravis Market Size

Myasthenia Gravis Market

Scope of Myasthenia Gravis Market Report

Chapter Outline

FEATURED COMPANIES